Quantitative & Regulatory Medical Science, LLC

Quantitative & Regulatory Medical Science (QRMedSci), LLC, founded by Qing Liu, Ph.D., is a consulting and media company in biostatistics consulting service, analytics development and media production for clinical research in trial designs, monitoring and analyses for the biopharmaceutical and medical device industry, and regulatory/government agencies. Biostatistics Consulting: Services include strategic clinical development plan, complex innovative trial design, medical and statistical monitoring, design modifications and statistical analysis, and project/resource management. • QRMedSci provides small and start-up companies with innovative clinical trial designs and technologies to bring promising medical treatments to market early and efficiently, while incorporating clients’ financial or funding challenges. Currently, QRMedSci focuses on consulting and research in medical devices, immuno-oncology, breakthrough designation drugs, gene therapies, rare disease drugs, and individualized medicine • Through partnership, QRMedSci provides full biostatistical and programming services for clinical trial design, interim and final analysis, study report and regulatory submissions. Media and Information Technology: QRMedSci is developing an innovative media and IT platform. • SlideKiq front-end technologies to publish and share media contents in social media platforms (e.g., Facebook and LinkedIn); Amazon AWS system to host SaaS analytics and web apps for clinical trial designs and program planning. • Various analytics for innovative clinical trial designs and analyses and for planning clinical development programs. • AppInDoc technologies to embed web app analytics in media contents.